Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

ATROPINE 1% EYE OINTMENT

Atropine Sulfate
$4.6754per GM
Low Outlier

Strength

10 mg/g

Manufacturer

Bausch & Lomb Incorporated

NDC

24208082555

Classification

Generic

Dosage Form

OINTMENT

Route

OPHTHALMIC

Last Updated

9/19/2018

Active Ingredients

ATROPINE SULFATE

Approval Type

Unapproved

On Market Since

9/30/1990

Pharmacological Classes

Anticholinergic
Cholinergic Antagonists
Cholinergic Muscarinic Antagonist
Cholinergic Muscarinic Antagonists

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

+14.4%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

OXYBUTYNIN 5 MG/5 ML SYRUP
Generic
54838051080•Lannett Company Inc.
$0.0321
per ML
OXYBUTYNIN 5 MG/5 ML SOLUTION
Generic
62135052047•Chartwell RX LLC
$0.0321
per ML
OXYBUTYNIN 5 MG TABLET
Generic
64380078108•Strides Pharma Inc.
$0.0468
per EA
OXYBUTYNIN 5 MG TABLET
Generic
00832003800•Upsher-Smith Laboratories LLC
$0.0484
per EA
OXYBUTYNIN 5 MG TABLET
Generic
00832003801•Upsher-Smith Laboratories LLC
$0.0484
per EA
OXYBUTYNIN 5 MG TABLET
Generic
00832003810•Upsher-Smith Laboratories LLC
$0.0484
per EA
OXYBUTYNIN 5 MG TABLET
Generic
00832003850•Upsher-Smith Laboratories LLC
$0.0484
per EA
OXYBUTYNIN 5 MG TABLET
Generic
00904702761•Major Pharmaceuticals
$0.0484
per EA
OXYBUTYNIN 5 MG TABLET
Generic
10702020101•KVK-Tech Inc.
$0.0484
per EA
OXYBUTYNIN 5 MG TABLET
Generic
10702020110•KVK-Tech Inc.
$0.0484
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy